Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.

We have studied the estrogenic regulation and the potential autocrine role of transforming growth factor alpha (TGF alpha) in the human breast cancer cell line MCF-7. A biologically active apparent mol wt 30 k TGF alpha was identified by gel filtration chromatography in medium conditioned by MCF-7 breast cancer cells. We previously reported induction of TGF alpha levels in medium by 17 beta-estradiol. We now report correlated increases in TGF alpha mRNA, by Northern and slot blot analysis, after estrogen treatment of MCF-7 cells in vitro. In vivo experiments confirmed these data: estrogen withdrawal from MCF-7 tumor-bearing nude mice resulted in a decline in tumor size and TGF alpha mRNA levels. To explore the functional significance of TGF alpha in MCF-7 cells, anti-TGF alpha antibody was added to MCF-7 soft agar cloning assays. Inhibition of MCF-7 growth resulted, supporting an autocrine role for TGF alpha. Further experiments using an anti-EGF receptor antibody expanded this data, demonstrating inhibition of estrogen-stimulated monolayer MCF-7 cell growth. Examining the generality of TGF alpha expression, 4.8 kilobase TGF alpha mRNAs were seen in three other human breast cancer cell lines, MDA-MB-231, ZR 75B, and T47D. Expression of TGF alpha mRNA was detected in 70% of estrogen receptor positive and negative primary human breast tumors from 40 patients when examined by slot blot and Northern analysis. Thus, we have demonstrated broad expression of TGF alpha in human breast cancer, its hormonal regulation in an estrogen-responsive cell line, and its possible functional significance in MCF-7 cell growth.

[1]  D. Kaufman,et al.  Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. , 1988, Molecular endocrinology.

[2]  A. Harris,et al.  Epidermal growth factor receptors in human breast cancer. , 1988, Cancer treatment and research.

[3]  R. Derynck,et al.  Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production. , 1987, Molecular endocrinology.

[4]  E. Gelmann,et al.  Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. , 1987, Molecular endocrinology.

[5]  M. Lippman,et al.  Estrogen inhibition of a Mr 39,000 glycoprotein secreted by human breast cancer cells. , 1987, Cancer research.

[6]  R. Derynck,et al.  Different transforming growth factor-α species are derived from a glycosylated and palmitoylated transmembrane precursor , 1987, Cell.

[7]  R. Derynck,et al.  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.

[8]  E. Gelmann,et al.  Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Goeddel,et al.  Synthesis of Messenger RNAs for Transforming Growth Factors α and β and the Epidermal Growth Factor Receptor by Human Tumors , 1987 .

[10]  D. D. Hoff,et al.  Assessment of Biological Activity of Linear α-Transforming Growth Factor and Monospecific Antibodies to α-Transforming Growth Factor and Linear α-Transforming Growth Factor , 1986 .

[11]  J. Tam,et al.  Efficient synthesis of human type alpha transforming growth factor: its physical and biological characterization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[12]  B. Kelly,et al.  Biologically active precursor for transforming growth factor type alpha, released by retrovirally transformed cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Dickson,et al.  Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. , 1986, Science.

[14]  R. Derynck,et al.  Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. , 1986, Science.

[15]  S. Bates,et al.  Characterization of estrogen responsive transforming activity in human breast cancer cell lines. , 1986, Cancer research.

[16]  H. Rochefort,et al.  Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. , 1986, Endocrinology.

[17]  B. Katzenellenbogen,et al.  Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Coffey,et al.  Production of transforming growth factors by human colon cancer lines. , 1986, Cancer Research.

[19]  G. Michalopoulos,et al.  Partial purification and characterization of a hepatocyte growth factor produced by rat hepatocellular carcinoma cells. , 1985, Cancer research.

[20]  H. Kurachi,et al.  Evidence for the involvement of the submandibular gland epidermal growth factor in mouse mammary tumorigenesis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCER , 1985, The Lancet.

[22]  G. Sherbet,et al.  EPIDERMAL-GROWTH-FACTOR RECEPTORS AND ESTROGEN-RECEPTORS IN HUMAN-BREAST CANCER , 1985 .

[23]  P. Linsley,et al.  Detection of larger polypeptides structurally and functionally related to type I transforming growth factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. E. Kudlow,et al.  Inability of anti-epidermal growth factor receptor monoclonal antibody to block "autocrine" growth stimulation in transforming growth factor-secreting melanoma cells. , 1984, The Journal of biological chemistry.

[25]  D. Salomon,et al.  Presence of transforming growth factors in human breast cancer cells. , 1984, Cancer research.

[26]  J. Wittliff,et al.  Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. , 1984, Cancer research.

[27]  G. Schultz,et al.  Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. , 1984, Cancer research.

[28]  E. S. Kimball,et al.  Epidermal growth factor (EGF) binding to membranes immobilized in microtiter wells and estimation of EGF-related transforming growth factor activity. , 1984, Biochimica et biophysica acta.

[29]  P Chambon,et al.  Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. , 1984, Nucleic acids research.

[30]  L. Hood,et al.  Rat transforming growth factor type 1: structure and relation to epidermal growth factor. , 1984, Science.

[31]  J. Mendelsohn,et al.  Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. , 1984, Cancer research.

[32]  L. Kedes,et al.  Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. , 1984, Nucleic acids research.

[33]  E. Chen,et al.  Human transforming growth factor-alpha: precursor structure and expression in E. coli. , 1984, Cell.

[34]  G. Carpenter,et al.  Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[35]  L. Hood,et al.  Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Moses,et al.  Transforming growth factors in solid human malignant neoplasms. , 1983, Cancer Research.

[37]  Y. Imai,et al.  Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture. , 1982, Cancer research.

[38]  B. Hamilton,et al.  Receptor binding and processing of epidermal growth factor by human breast cancer cells. , 1982, The Journal of clinical endocrinology and metabolism.

[39]  G. Todaro,et al.  Human transforming growth factor. Production by a melanoma cell line, purification, and initial characterization. , 1982, The Journal of biological chemistry.

[40]  Lipsett Mb,et al.  Endocrine responsive cancers of man. , 1981 .

[41]  M. Sporn,et al.  Autocrine secretion and malignant transformation of cells. , 1980, The New England journal of medicine.

[42]  G. Todaro,et al.  Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Lippman,et al.  The effects of 17 beta estradiol and tamoxifen on the ZR-75-1 human breast cancer cell line in defined medium. , 1980, European journal of cancer.

[44]  C. Osborne,et al.  Epidermal growth factor stimulation of human breast cancer cells in culture. , 1980, Cancer research.

[45]  M. Sporn,et al.  Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Todaro,et al.  Sarcoma growth factor from mouse sarcoma virus-transformed cells. Purification by binding and elution from epidermal growth factor receptor-rich cells. , 1980, The Journal of biological chemistry.

[47]  D. Edwards,et al.  Estrogen induced synthesis of specific proteins in human breast cancer cells. , 1980, Biochemical and biophysical research communications.

[48]  G. Todaro,et al.  Growth factors from murine sarcoma virus-transformed cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[49]  E. L. Springer,et al.  Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. , 1977, Journal of the National Cancer Institute.

[50]  M. Lippman,et al.  A simple computer program for quantitation and Scatchard analysis of steroid receptor proteins. , 1977, Journal of steroid biochemistry.

[51]  A. Long,et al.  A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.

[52]  M. Sporn,et al.  Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type a and type f 8 transforming growth factors ( soft agar growth / epidermal growth factor / cell transformation / HPLC purification ) , 2022 .